NEOVASC Forum: Community User: xxFairTraderxx

Bin mal rein bei 0,033 € Vielleicht klappt der Zock

Hast du mal nachgeschaut was Penn für ein Netzwerk bestehend aus Krankenhäusern , Forschungszentren etc hat ??! Das ist der Schlüssel zum US Markt der bis dato praktisch unangetastet war ......

Erklär mal bitte kurz, warum es eine gute Nachricht sein soll, dass sie jetzt mind. 4 Jahre lang für jeden Tiara-Verkauf Prozente an Penn abdrücken müssen. Was ist die Gegenleistung? Welche "certain potential claims against the company" werden gelöst?

Spread heute morgen nur etwas über 10% ;) !!!! Schnappt euch die letzten günstigen Shares . Die 4cent sind bald Geschichte !!!!

Earnings Call ist auch noch am Mittwoch Abend nach Börsenschluss. Wird echt ne spannende Woche

Ohh zeit zum zocken auf ne ergolgreiche grüne woche bisher deutlich todesspirale

Danke hoffe mal das wir langsam plus schreiben

Hier nochmal die News reinkopiert ;)

Neovasc Inc Symbol C : NVCN Shares Issued 1,875,216,663 Close 2018-08-03 C$ 0.045 Recent Sedar Documents View Original Document Neovasc to collaborate with U. of Pennsylvania 2018-08-03 17:45 ET - News Release Mr. Fred Colen reports NEOVASC ANNOUNCES COLLABORATION AND LICENSING AGREEMENT WITH PENN MEDICINE AND THE GORMAN CARDIOVASCULAR RESEARCH GROUP Neovasc Inc. has entered into a collaboration and licensing agreement relating to certain know-how developed by Penn Medicine and the Gorman Cardiovascular Research Group at the University of Pennsylvania. This agreement resolves certain potential claims against the company that were described in the company's annual report on Form 20-F and management's discussion and analysis for Q1. This agreement does not impact either Penn or Neovasc's patent rights. Tiara is Neovasc's minimally invasive transcatheter device for patients who experience severe mitral regurgitation (MR). There are millions of patients worldwide who suffer from severe MR, a significant percentage of whom are not good candidates for conventional surgical repair or replacement. Tiara is implanted in the heart using a minimally invasive, transapical transcatheter approach without the need for open-heart surgery or use of a cardiac bypass machine. This collaboration and licensing agreement contemplates a period of collaboration over the next four years with fees being paid by Neovasc to Penn. Following the first commercial sale of the Tiara, Neovasc will pay a stepped royalty on Tiara revenues. These royalty obligations continue after the four-year collaboration period has ended. Also contained in the collaboration and licensing agreement are buyout clauses that allow Neovasc, or an acquirer of Neovasc or the Tiara assets, to buy out these royalty obligations. For further details, please see the material change report filed by the company on SEDAR and furnished to the SEC on EDGAR under Form 6-K. "This agreement helps to safeguard our efforts to further develop and commercialize the Tiara. We are pleased to have resolved this matter in a manner that allows Neovasc to advance the Tiara program development in the near term, while providing an option to either Neovasc or an acquirer of Neovasc to buy out these future royalty obligations," commented Fred Colen, Neovasc's chief executive officer.

News Link lesen !!! Haben einen Partner gefunden ;)

Axelrod83 warum endlich haben die Genehmigung bekommen???

Montag dann hoffentlich die Auferstehung von den Toten ;)

Endlich !!!!!!! https://finance.yahoo.com/news/neovasc-announces-collaboration-licensing-agreement-213400801.html

Was ist denn Heute los?

Generell sind die spreads heute Abend wegen dem frühen US Börsenschluss und morgigem Feiertag eine absolute Frechheit

The Wolf of Wall Street lässt grüßen. ;D